YIMDI
Live / Allowed — Notice of allowance issued (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99345781
- Mark type
- Stylized text
- Filed
- 19 Aug 2025
- Published for opposition
- 03 Feb 2026
- Attorney of record
- Kristen S Ruisi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for use in the treatment of Tourette Syndrome; Pharmaceutical preparations and substances for use in the treatment of Restless Legs Syndrome with Augmentation; Pharmaceutical preparations and substances for use in the treatment of central nervous system disorders
Owner
- Emalex Biosciences, Inc., Chicago, IL, US
- Emalex Biosciences, Inc., Chicago, IL, US
Prosecution history
- 31 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Feb 2026 — PUBLISHED FOR OPPOSITION
- 28 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 06 Jan 2026 — ASSIGNED TO EXAMINER
- 19 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 19 Aug 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 19 Aug 2025 — NEW APPLICATION ENTERED